CHUN YIU CHOW: Open Payments
NPI 1356971907 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 35 payments from 14 companies in 2025. Trend: 2023 $653 · 2024 $359 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
| UCB, Inc. | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| ANI Pharmaceuticals, Inc. | 3 | $70 |
| Amgen Inc. | 3 | $65 |
| GENZYME CORPORATION | 2 | $64 |
| Mallinckrodt Hospital Products Inc. | 2 | $58 |
| Optinose US, Inc. | 2 | $43 |
Products named: DUPIXENT, Bimzelx, NEFFY, PURIFIED CORTROPHIN GEL, ACTHAR, BENLYSTA, TAVNEOS, Xhance.
Industry payments across TX — which companies pay providers there.
